Dear editor,

We read with interest the article by [@b0005]. This letter aims at offering an alternative viewpoint on the pathophysiological mechanisms underlying SARS-CoV2 neuroinvasion. As elegantly reported by the Authors, direct neuroinvasion via hematogenous spread or migration through the olfactory tract are possible infection routes to the Central Nervous System (CNS). However, the virus could also gain access to the CNS from the periphery and, notably, the brainstem invasion via the vagal afferents from the lung and upper airways has been postulated in COVID-19 patients ([@b0010]).

In this context, the gastrointestinal (GI) tract emerges as a largely underestimated niche for viral replication, given 1) the higher relative expression of ACE-2 receptor along the GI epithelium than in the lungs 2) the evidence that SARS-CoV-2 is able to directly infect and replicate in intestinal cells 3) the worse clinical outcome of COVID-19 patients with concomitant GI symptoms with increased acute respiratory distress and need of mechanical ventilation ([@b0015]).

[@b0020] showed that in Middle East Respiratory Syndrome coronavirus (MERS-CoV) the enteric involvement could precede the respiratory infection and observed brain infection in intranasally injected mice with MERS-CoV. More surprisingly, they also described increased viral load in brains from infected mice by intragastric inoculation. In these mice, indeed, direct intragastric gavage spread infectious virions in both lung and brain homogenates 5 days after the inoculation.

The digestive tract is largely exposed to a variety of immunogenic noxae from the external world in the form of ingested particles, including viruses. Increasing evidence supports the hypothesis that the gut may be the "entrance door" by which prions or viruses may: (1) directly neuroinvade or indirectly immunologically prime the enteric nervous system (ENS) and (2) ascend to the CNS through intestinal vagal afferents.

The ENS is strictly interconnected with the enteric glial cells (EGCs) and the gut epithelium cooperating in a neuro-epithelial unit that is key to gut homeostasis. EGCs express the major histocompatibility complex II and respond to harmful stimuli mainly through the Toll-like receptors-2 and -4, regulating the neuro-immune axis and defending the host against gut pathogens.

EGCs are antigen presenting cells to innate and adaptive immune cells housed in the so-called gut-associated lymphoid tissue (GALT), representing de facto the central repository of these lymphocytes in the body and coordinate the transition from naïve CD4+ lymphocytes to different subtypes.

In keeping with this, EGCs activation by viruses or their antigens, is a key step for the peripheral neuroglial immune priming by viruses and is responsible for late onset of neurological impairment, through a gut-brain axis for neuroinvasion ([@b0025]). Finally, EGCs activation is accompanied by a massive release of IL-6 and other inflammatory mediators that could contribute to acute respiratory distress as observed in the COVID19-induced cytokine storm ([Fig. 1](#f0005){ref-type="fig"} ).Fig. 1The Enteric nervous system and its potential involvement in SARS-CoV2 neuroinvasion.

A growing number of scientists are now considering the SARS-CoV-2 related-diarrhea, not a merely accessory symptom. The GI dysfunction is a possible marker of involvement of ENS/EGC, offering an alternative pathophysiological mechanism underlying SARS-CoV2 neuroinvasion.
